We are live on ! Find out more
BP

Ballentine Partners Portfolio holdings

AUM $8.18B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
-0.25%
1 Year Est. Return
+27.59%
3 Year Est. Return
+76.88%
5 Year Est. Return
+72.28%
10 Year Est. Return
+235.36%
AUM
$744M
AUM Growth
Cap. Flow
+$760M
Cap. Flow %
102.24%
Top 10 Hldgs %
67.03%
Holding
127
New
127
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 4.03%
2 Technology 0.9%
3 Healthcare 0.83%
4 Industrials 0.78%
5 Consumer Staples 0.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCRT icon
126
Alaunos Therapeutics
TCRT
$4.64M
$46K 0.01%
+146
New +$40.5K
SIRI icon
127
SiriusXM
SIRI
$10.7B
$40K 0.01%
+1,219
New +$40.1K

Similar funds

Ballentine Partners's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Ballentine Partners, which disclosed 127 positions worth $744M. Its ten largest holdings account for 67% of the portfolio.

Its largest position is Vanguard Total Stock Market ETF: 1,160,079 shares worth $95.9M.

By sector, the portfolio is most concentrated in Financials at 4% of assets, followed by Technology and Healthcare.

  • Ballentine Partners's largest Q2 2013 buy was Vanguard Total Stock Market ETF: 1,160,079 shares worth $95.9M.
  • Ballentine Partners's ten largest holdings make up 67% of its $744M portfolio in Q2 2013.
  • Ballentine Partners disclosed 127 positions in Q2 2013, its first 13F filing on record.

Based on Ballentine Partners's 13F filing for Q2 2013, filed 24 Jul 2013.